RXHN Insider Trading Activity and SEC Form 4 Filings
RXHN insider trading summary
No open-market insider purchases or sales of Rexahn Pharmaceuticals, Inc. (RXHN) have been reported on SEC Form 4 in the past 12 months.
Latest RXHN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 11, 2006 | Young Soon Park | Director | Sell | $119K (384,500 @ $0.31) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.